Thornberry Nancy (CIK 1797826) reported 9 SEC Form 4 insider transactions across 3 companies over the past 18 months (most recent 2026-09-04). Recent activity: Sell DNLI (10,824 shares), Sell DNLI (615 shares), Buy SDGR (8,141 shares), Buy DNLI (6,408 shares), Buy VRTX (472 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-09-04 | Denali Therapeutics Inc. (DNLI) | Director | Sell | 10,824 | $247,328 |
| 2026-09-04 | Denali Therapeutics Inc. (DNLI) | Director | Sell | 615 | $14,600 |
| 2026-06-23 | Schrodinger, Inc. (SDGR) | Director | Buy | 8,141 | $0 |
| 2026-06-05 | Denali Therapeutics Inc. (DNLI) | Director | Buy | 6,408 | $0 |
| 2026-05-05 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | Director | Buy | 472 | $0 |
| 2026-05-05 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | Director | Sell | 398 | $0 |
| 2025-06-20 | Schrodinger, Inc. (SDGR) | Director | Buy | 5,997 | $0 |
| 2025-06-05 | Denali Therapeutics Inc. (DNLI) | Director | Buy | 6,037 | $0 |
| 2025-05-05 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | Director | Buy | 398 | $0 |
来源：SEC Form 4 申报文件 · 截至 2026-09-04